Security readout for executives and security teams
Plain-English summary
Philips Holter 2010 Plus systems, all versions, have a reported weakness that may let someone enable system options the organization did not purchase. The supplied sources do not show clinical harm, data compromise, active exploitation, CVSS severity, or confirmed patch details.
Executive priority
Do not treat this as an internet-scale emergency based on supplied evidence. Prioritize asset identification, entitlement review, and vendor guidance confirmation for any active Holter 2010 Plus deployments.
Technical view
CVE-2019-10968 affects Philips Holter 2010 Plus, all versions. The vulnerability is described as allowing system options that were not purchased to be enabled. The bundle lists CWE-477, but provides no attack vector, privileges required, preconditions, CVSS score, or remediation specifics.
Likely exposure
Exposure appears limited to organizations operating Philips Holter 2010 Plus systems. The source bundle does not identify network exposure requirements, hosted services, dependencies, or other Philips products as affected.
Exploitation context
The source bundle does not support active exploitation. The CVE is not listed as KEV, and no provided source describes public exploitation, weaponization, or observed attacks.
Researcher notes
The public bundle is sparse. Key missing facts include CVSS, exploitation prerequisites, affected deployment modes, vendor fix availability, and operational impact beyond unauthorized option enablement. Avoid extrapolating to other Philips products.
Mitigation direction
- Inventory Philips Holter 2010 Plus deployments and versions.
- Review the Philips and CISA advisory for vendor-approved guidance.
- Restrict administrative access to the Holter system.
- Monitor for unauthorized feature or option enablement.
- Document compensating controls until vendor remediation is confirmed.
Validation and detection
- Confirm whether any Holter 2010 Plus systems remain in use.
- Review enabled options against purchased entitlements.
- Check administrative access logs where available.
- Verify local support teams know the vendor guidance status.
- Record findings in medical device risk tracking.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-477: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2019-10968 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://www.us-cert.gov/ics/advisories/icsma-19-192-01CVE reference · x_refsource_MISC
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Use of Obsolete Function
Use of Obsolete Function represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.